GlassScriptPhysician profile
Gabriel Victor
NPI 1629061445
$14,459.99
in general payments reported to CMS, 2019-2025
22 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,880 · 2020: $1,309 · 2021: $1,509 · 2022: $2,070 · 2023: $2,351 · 2024: $2,154 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,611 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,611.01 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,478.40 | 2019-2025 | Aveir, Assurity, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,833.78 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $1,416.35 | 2019-2025 | Watchman Flx, General - Atherectomy |
| Alexion Pharmaceuticals, INC. | $963.99 | 2019-2023 | |
| Melinta Therapeutics, LLC | $500.91 | 2023-2024 | Rezzayo, Kimyrsa, Vabomere |
| Inari Medical, INC. | $478.95 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $368.79 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Horizon Therapeutics Plc | $358.67 | 2022-2023 | Krystexxa |
| Penumbra, INC. | $358.31 | 2022-2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $250.00 | 2019-2023 | Xarelto |
| Edwards Lifesciences Corporation | $185.43 | 2022 | |
| Stryker Corporation | $166.56 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $162.66 | 2019 | |
| Integra Lifesciences Corporation | $160.87 | 2023 | Integra, Omnigraft, Surgimend |
| Allergan, INC. | $149.70 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $147.91 | 2024 | |
| Amgen INC. | $133.81 | 2025 | Krystexxa |
| Actelion Pharmaceuticals US, INC. | $122.17 | 2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $118.01 | 2024 | |
| Astellas Pharma US INC | $79.99 | 2025 | |
| Pfizer INC. | $20.18 | 2022 | |
| Impulse Dynamics (USA) INC. | $4.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Victor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.